-
1
-
-
0033847343
-
Anemia of the critically ill: "Acute" anemia of chronic disease
-
Corwin HL, Krantz SB: Anemia of the critically ill: "Acute" anemia of chronic disease. Crit Care Med 2000; 28:3098-3099
-
(2000)
Crit Care Med
, vol.28
, pp. 3098-3099
-
-
Corwin, H.L.1
Krantz, S.B.2
-
2
-
-
9144245515
-
The CRIT Study: Anemia and blood transfusion in the critically ill. Current clinical practice in the United States
-
Corwin HL, Gettinger A, Pearl RG, et al: The CRIT Study: Anemia and blood transfusion in the critically ill. Current clinical practice in the United States. Crit Care Med 2004; 32:39-52
-
(2004)
Crit Care Med
, vol.32
, pp. 39-52
-
-
Corwin, H.L.1
Gettinger, A.2
Pearl, R.G.3
-
3
-
-
0037174359
-
Anemia and blood transfusion in critically ill patients
-
Vincent JL, Baron JF, Reinhart K, et al: Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507
-
(2002)
JAMA
, vol.288
, pp. 1499-1507
-
-
Vincent, J.L.1
Baron, J.F.2
Reinhart, K.3
-
4
-
-
0033397526
-
Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients
-
von Ahsen N, Muller C, Serke S, et al: Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999; 27:2630-2639
-
(1999)
Crit Care Med
, vol.27
, pp. 2630-2639
-
-
Von Ahsen, N.1
Muller, C.2
Serke, S.3
-
5
-
-
0031039124
-
Erythropoietin response is blunted in critically ill patients
-
Rogiers P, Zhang H, Leeman M, et al: Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23:159-162
-
(1997)
Intensive Care Med
, vol.23
, pp. 159-162
-
-
Rogiers, P.1
Zhang, H.2
Leeman, M.3
-
6
-
-
0035092672
-
Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness
-
Rodriguez RM, Corwin HL, Gettinger A, et al: Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001; 16:36-41
-
(2001)
J Crit Care
, vol.16
, pp. 36-41
-
-
Rodriguez, R.M.1
Corwin, H.L.2
Gettinger, A.3
-
7
-
-
0033838942
-
Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients
-
van Iperen CE, Gaillard CA, Kraaijenhagen RJ, et al: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000; 28:2773-2778
-
(2000)
Crit Care Med
, vol.28
, pp. 2773-2778
-
-
Van Iperen, C.E.1
Gaillard, C.A.2
Kraaijenhagen, R.J.3
-
8
-
-
0032760409
-
Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial
-
Corwin HL, Gettinger A, Rodriguez RM, et al: Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27:2346-2350
-
(1999)
Crit Care Med
, vol.27
, pp. 2346-2350
-
-
Corwin, H.L.1
Gettinger, A.2
Rodriguez, R.M.3
-
9
-
-
0037065340
-
Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial
-
Corwin HL, Gettinger A, Pearl RG, et al: Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA 2002; 288:2827-2835
-
(2002)
JAMA
, vol.288
, pp. 2827-2835
-
-
Corwin, H.L.1
Gettinger, A.2
Pearl, R.G.3
-
10
-
-
0031044609
-
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
-
Procrit Study Group
-
Glaspy J, Bukowski R, Steinberg D, et al: Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997; 15:1218-1234
-
(1997)
J Clin Oncol
, vol.15
, pp. 1218-1234
-
-
Glaspy, J.1
Bukowski, R.2
Steinberg, D.3
-
11
-
-
0031785826
-
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
-
Procrit Study Group
-
Demetri GD, Kris M, Wade J, et al: Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998; 16:3412-3425
-
(1998)
J Clin Oncol
, vol.16
, pp. 3412-3425
-
-
Demetri, G.D.1
Kris, M.2
Wade, J.3
-
12
-
-
0035367087
-
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
-
Littlewood TJ, Bajetta E, Nortier JW, et al: Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001; 19:2865-2874
-
(2001)
J Clin Oncol
, vol.19
, pp. 2865-2874
-
-
Littlewood, T.J.1
Bajetta, E.2
Nortier, J.W.3
-
13
-
-
0031684212
-
Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects
-
Cheung WK, Goon BL, Guilfoyle MC, et al: Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects. Clin Pharmacol Ther 1998; 64:412-423
-
(1998)
Clin Pharmacol Ther
, vol.64
, pp. 412-423
-
-
Cheung, W.K.1
Goon, B.L.2
Guilfoyle, M.C.3
-
14
-
-
0035433756
-
Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly
-
Cheung W, Minton N, Gunawardena K: Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly. Eur J Clin Pharmacol 2001; 57:411-418
-
(2001)
Eur J Clin Pharmacol
, vol.57
, pp. 411-418
-
-
Cheung, W.1
Minton, N.2
Gunawardena, K.3
-
15
-
-
0035366382
-
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
-
Gabrilove JL, Cleeland CS, Livingston RB, et al: Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 2001; 19:2875-2882
-
(2001)
J Clin Oncol
, vol.19
, pp. 2875-2882
-
-
Gabrilove, J.L.1
Cleeland, C.S.2
Livingston, R.B.3
-
16
-
-
0031735051
-
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicentric, prospective study
-
Vincent JL, de Mendonça A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicentric, prospective study. Crit Care Med 1998; 26:1793-1800
-
(1998)
Crit Care Med
, vol.26
, pp. 1793-1800
-
-
Vincent, J.L.1
De Mendonça, A.2
Cantraine, F.3
-
17
-
-
0025241454
-
Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers
-
McMahon FG, Vargas R, Ryan M, et al: Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 1990; 76:1718-1722
-
(1990)
Blood
, vol.76
, pp. 1718-1722
-
-
McMahon, F.G.1
Vargas, R.2
Ryan, M.3
|